Dr Shahid Uddin is currently Senior Director of Drug Product, Formulation & Stability within the CMC department at Immunocore. His team is responsible for bringing research candidates into clinic and commercialisation. Technology is focussed around developing ImmTAC® as therapeutic agents for different disease models. Prior to this he held the position of Head of Formulation at MedImmune (AstraZeneca) where he supported the biologics portfolio covering Monoclonal antibodies, Peptides, bispecifics and other proteins. He has extensive experience in pre-formulation/formulation, forced degradation , delivery of biologics both for early and late stage programmes